v3.21.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 278 $ 466 $ 864 $ 2,382
General and administrative 594 571 1,960 1,832
Loss from operations (872) (1,037) (2,824) (4,214)
Interest income (1) (9) (6) (56)
Net Loss $ (871) $ (1,028) $ (2,818) $ (4,158)
Net loss per common share outstanding, basic $ (0.05) $ (0.06) $ (0.17) $ (0.25)
Net loss per common share outstanding, diluted $ (0.05) $ (0.06) $ (0.17) $ (0.25)
Weighted average number of common shares outstanding, basic 16,627,427 16,519,464 16,580,283 16,489,701
Weighted average number of common shares outstanding, diluted 16,627,427 16,519,464 16,580,283 16,489,701

Source